03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: INF14<br />

MultiStage: No<br />

DXCat Label: Leprosy (Hansen's disease) Specificity: A<br />

Etiology:<br />

Infection, Bacterial<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

0.00 Screening for Hansen's disease<br />

DX V742;<br />

1.01 Indeterminate leprosy Hypopigmented and/or erythematous macule with or without paresthesia or anesthesia<br />

[dermatology report]<br />

DX 0302, 0308-0309;<br />

AND non-specific findings of skin biopsy [pathology report<br />

AND bacteriological findings, AFB negative [laboratory report]<br />

AND Mitsuda reaction negative<br />

1.02 Tuberculoid type Stage 1.01<br />

DX 0301;<br />

AND a few asymmetrical anesthetic annular skin lesions [dermatology report]<br />

AND tuberculoid granulomas [pathology report]<br />

AND bacteriological findings, AFB stain negative [laboratory report]<br />

1.03 Borderline group (borderline tuberculoid,<br />

borderline borderline, borderline<br />

lepromatous)<br />

Stage 1.01-1.02<br />

AND multiple symmetrical and/or asymmetrical anesthetic to infiltrated lesions [dermatology<br />

report]<br />

AND predominance of tuberculoid granulomas or foamy macrophages infiltration [pathology<br />

report]<br />

AND bacteriological findings, AFB stain weakly to moderately positive [laboratory report]<br />

DX 0303;<br />

1.04 Lepromatous type Stage 1.01-1.03<br />

AND multiple symmetrical skin lesions<br />

AND leonine facies (dermatology report)<br />

AND diffuse foamy macrophages infiltration [pathology report]<br />

AND bacteriological findings, AFB stain strongly positive [laboratory report]<br />

DX 0300;<br />

2.01 Type I reaction (Downgrading or<br />

upgrading)<br />

OR Type II reaction (erythema nodosum<br />

leprosum)<br />

Type I reaction:<br />

Stage 1.03<br />

AND acute neuritis and/or acutely inflammed skin lesions [dermatology report]<br />

Type II reaction:<br />

Stage 1.03 (borderline lepromatous)<br />

AND Stage 1.04<br />

AND multiple painful erythematous nodules on the face and extensor surfaces with<br />

ulceration and suppuration (dermatology report)<br />

AND fever<br />

AND arthralgias<br />

AND lymphadenopathy<br />

AND uveitis<br />

AND neutrophil skin infiltration with vasculitis (pathology report)<br />

STAGE 1.01-1.04 + (DX 6952,<br />

69589-6959);<br />

Thursday, January 07, 2010 9:22:24 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!